Rofecoxib-induced renal dysfunction in a patient with compensated cirrhosis and heart failure

Am J Gastroenterol. 2001 Jun;96(6):1941. doi: 10.1111/j.1572-0241.2001.03905.x.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Cyclooxygenase 2
  • Cyclooxygenase 2 Inhibitors
  • Cyclooxygenase Inhibitors / adverse effects*
  • Female
  • Fibrosis
  • Heart Failure / complications*
  • Heart Failure / pathology
  • Humans
  • Isoenzymes / antagonists & inhibitors*
  • Lactones / adverse effects*
  • Membrane Proteins
  • Middle Aged
  • Myocardium / pathology
  • Prostaglandin-Endoperoxide Synthases
  • Renal Insufficiency / chemically induced*
  • Renal Insufficiency / complications
  • Sulfones

Substances

  • Cyclooxygenase 2 Inhibitors
  • Cyclooxygenase Inhibitors
  • Isoenzymes
  • Lactones
  • Membrane Proteins
  • Sulfones
  • rofecoxib
  • Cyclooxygenase 2
  • PTGS2 protein, human
  • Prostaglandin-Endoperoxide Synthases